Skip to search.
 FTSE 100 Up 0.17%

More On GLAXF

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

GlaxoSmithKline plc (GLAXF)

-Other OTC Ticker: 925288/ISIN: GB0009252882
23.91 Up 0.31(1.29%) 3 Mar 19:56
Add to Portfolio
Prev Close:23.60
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:20.50 - 28.56
Volume:0
Avg Vol (3m):6,822
Market Cap:N/A
P/E (ttm):27.35
EPS (ttm):0.87
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):0.26
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :90.39
Quarterly EPS Est (Mar-15) :20.40
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):4.34

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback